[go: up one dir, main page]

CL2012001269A1 - Di-substituted bi-imidazole derived compounds; pharmaceutical composition comprising said compound; and its use to treat hepatitis C virus (HCV) infections. - Google Patents

Di-substituted bi-imidazole derived compounds; pharmaceutical composition comprising said compound; and its use to treat hepatitis C virus (HCV) infections.

Info

Publication number
CL2012001269A1
CL2012001269A1 CL2012001269A CL2012001269A CL2012001269A1 CL 2012001269 A1 CL2012001269 A1 CL 2012001269A1 CL 2012001269 A CL2012001269 A CL 2012001269A CL 2012001269 A CL2012001269 A CL 2012001269A CL 2012001269 A1 CL2012001269 A1 CL 2012001269A1
Authority
CL
Chile
Prior art keywords
hcv
virus
compound
infections
substituted
Prior art date
Application number
CL2012001269A
Other languages
Spanish (es)
Inventor
Bachand Carol
h deon Daniel
a james Clint
Martell Alain
H Ruediger Edward
Goodrich Jason
C Good Andrew
d lopez Omar
A Meanwell Nicholas
N Nguyen Van
b snyder Lawrence
Yang Fukang
R Langley David
Wang Gan
G Hamann Lawrence
Belena Makonen
Lavoie Ricco
R St Lawrent Denis
Lee Romine Jefrey
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Priority to CL2012001269A priority Critical patent/CL2012001269A1/en
Publication of CL2012001269A1 publication Critical patent/CL2012001269A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A COMPUESTO, COMPOSICIONES Y MÉTODOS PARA EL TRATAMIENTO DE LA INFECCIÓN DE VIRUS DEL VIRUS DE LA HEPATITIS C (VHC). TAMBIÉN SE DESCRIBEN COMPOSICIONES FARMACÉUTICAS QUE CONTIENEN TALES COMPUESTOS Y MÉTODOS PARA USAR ESTOS COMPUESTOS EN EL TRATAMIENTO DE LA INFECCIÓN POR VHC.THE PRESENT INVENTION REFERS TO COMPOUND, COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEPATITIS C VIRUS (HCV) VIRUS INFECTION. PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS FOR USING THESE COMPOUNDS IN THE TREATMENT OF HCV INFECTION ARE ALSO DESCRIBED.

CL2012001269A 2012-05-15 2012-05-15 Di-substituted bi-imidazole derived compounds; pharmaceutical composition comprising said compound; and its use to treat hepatitis C virus (HCV) infections. CL2012001269A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CL2012001269A CL2012001269A1 (en) 2012-05-15 2012-05-15 Di-substituted bi-imidazole derived compounds; pharmaceutical composition comprising said compound; and its use to treat hepatitis C virus (HCV) infections.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2012001269A CL2012001269A1 (en) 2012-05-15 2012-05-15 Di-substituted bi-imidazole derived compounds; pharmaceutical composition comprising said compound; and its use to treat hepatitis C virus (HCV) infections.

Publications (1)

Publication Number Publication Date
CL2012001269A1 true CL2012001269A1 (en) 2012-08-17

Family

ID=69590318

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2012001269A CL2012001269A1 (en) 2012-05-15 2012-05-15 Di-substituted bi-imidazole derived compounds; pharmaceutical composition comprising said compound; and its use to treat hepatitis C virus (HCV) infections.

Country Status (1)

Country Link
CL (1) CL2012001269A1 (en)

Similar Documents

Publication Publication Date Title
UY33897A (en) HEPATITIS C VIRUS INHIBITORS
CO6290682A2 (en) INHIBITING FUSIONED TRICICLIC COMPOUNDS OF HEPATITIS VIRUS C.
CO6400192A2 (en) HEPATITIS C VIRUS INHIBITORS
CL2016000493A1 (en) Hcv polymerase inhibitors
CO6561788A2 (en) HEPATITIS C VIRUS INHIBITORS
BR112013002729A2 (en) hepatitis c virus inhibitors
ECSP13012622A (en) ANTIVIRAL COMPOUNDS
BR112013003101A2 (en) hepatitis c virus inhibitors
CL2015003298A1 (en) Novel bridged heteroaryl dihydropyrimidines in 6 for the treatment and prophylaxis of hepatitis B virus infection
EA201691261A1 (en) NEW DIHYDROCHINOLYSINES FOR THE TREATMENT AND PREVENTION OF INFECTION CAUSED BY THE HEPATITIS B VIRUS
BR112014030639A2 (en) macrocyclic flaviviridae virus inhibitors
BR112014030630A2 (en) macrocyclic flaviviridae virus inhibitors
CL2014003634A1 (en) Hepatitis C virus inhibitors
GT201200257A (en) SOLID COMPOSITIONS
BR112014030649A2 (en) macrocyclic flaviviridae virus inhibitors
CL2011002830A1 (en) Compounds derived from haloalkyl heteroaryl benzamides; pharmaceutical composition use of the composition in the treatment of a viral infection, such as hepatitis b and c virus.
UY34066A (en) HEPATITIS C VIRUS INHIBITORS
CU23938B1 (en) HUMAN UNION MOLECULES CAPABLE OF NEUTRALIZING THE H3N2 INFLUENZA VIRUS
GT201500021A (en) SULFAMOILARILAMIDAS AND ITS USE AS MEDICINES FOR THE TREATMENT OF HEPATITIS B
UA116083C2 (en) PURINE DERIVATIVES FOR TREATMENT OF VIRAL INFECTIONS
EA201791916A1 (en) 2'-SUBSTITUTED CARBANECULOSE ANALOGUES FOR ANTI-VIRUS TREATMENT
CO6440581A2 (en) HEPATITIS C VIRUS INHIBITORS
PH12014500385A1 (en) Benzofuran compounds for the treatment of hepatitis c virus infections
BR112014015582A2 (en) antiviral compounds
CL2016000300A1 (en) Therapeutic methods